Published in Drug Law Weekly, March 10th, 2009
Dr. von Eschenbach, who resigned as FDA Commissioner in January after leading the agency since 2005, will offer strategic counsel to Greenleaf's clients. Dr. von Eschenbach, an oncologist who previously served as director of the National Cancer Institute...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.